IPP Bureau
Tavneos (avacopan) approved for ANCA associated vasculitis in Japan
By IPP Bureau - September 28, 2021
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
Larsen & Toubro Infotech partners with eClinicalHealth to accelerate clinical research
By IPP Bureau - September 28, 2021
As part of this strategic partnership, LTI with its digital, technical and life sciences domain capabilities, will help accelerate joint go-to-market pursuits and faster deployment for Clinpal Adopters
Zymo Research donates one million Covid-19 test kits to Mapmygenome
By IPP Bureau - September 28, 2021
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
SpeeDx and SynGenis partner for custom oligonucleotide synthesis
By IPP Bureau - September 28, 2021
The investment will increase SpeeDx internal capacity to scale up manufacturing
Bal Pharma ramps up API capacity of Gliclazide
By IPP Bureau - September 28, 2021
In terms of volume, the company commands a market share 25 per cent globally for Gliclazide, as per the IQVIA report
Sun Pharma launches novel cough medicine
By IPP Bureau - September 28, 2021
Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustained release of the drug
B2B pharma start-up MEDdelivery raises US $ 1 million
By IPP Bureau - September 28, 2021
The company operates in over eight cities and the start-up plans to expand its reach to over 100 non-metro cities in the next 18-24 months
Flex Films launches F-UHB-M film to replace aluminium foil
By IPP Bureau - September 27, 2021
A high-value proposition recyclable film packed with industry-leading barrier and metal bond performance, sustainability quotient and U.S. FDA compliant
PM Modi launches Ayushman Bharat Digital Mission
By IPP Bureau - September 27, 2021
The Mission will simplify hospital processes and will increase Ease of Living. Under this, every citizen will get a digital health ID and their health record will be digitally protected.
QMS Medical partners with ZEISS for screening diabetic retinopathy
By IPP Bureau - September 27, 2021
Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Fujifilm to verify effectiveness of AI technology in health screening services
By IPP Bureau - September 27, 2021
This project will be conducted at the “NURA,” a health screening centre that Fujifilm opened in India in February this year
U.S. FDA approves Repatha for paediatric patients aged 10 years and older
By IPP Bureau - September 27, 2021
The FDA also approved Repatha as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia (HoFH) for younger pediatric patients
Cadila Healthcare signs agreement with Shilpa Medicare for production of ZyCoV-D
By IPP Bureau - September 26, 2021
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
U.S. FDA completes inspection of Biocon Biologics, Malaysia with six observations
By IPP Bureau - September 26, 2021
The company does not expect the outcome of this inspection to impact its plans
SAB Biotherapeutics’ SAB-185 moves to Phase 3 trial for Covid-19 treatment
By IPP Bureau - September 26, 2021
Advancement to Phase 3 is a major milestone for SAB’s unique DiversitAb immunotherapy platform that produces fully human polyclonal antibodies without human donors
